Moreover, the levels of adiponectin, an adipokine with anti-inflammatory and anti-atherogenic properties, are typically lower in individuals with obesity and diabetes. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.